Lifecome Biochemistry Co Ltd

SHE:002868 China Biotechnology
Market Cap
$853.20 Million
CN¥6.26 Billion CNY
Market Cap Rank
#10412 Global
#2301 in China
Share Price
CN¥40.28
Change (1 day)
-1.23%
52-Week Range
CN¥13.86 - CN¥46.40
All Time High
CN¥61.57
About

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, photovoltaic film products, etc.; veterinary drugs; and food preservatives. The company was founded in 2003 and is based in Pucheng, China.

Lifecome Biochemistry Co Ltd - Asset Resilience Ratio

Latest as of September 2020: 4.69%

Lifecome Biochemistry Co Ltd (002868) has an Asset Resilience Ratio of 4.69% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥45.35 Million
Cash + Short-term Investments
Total Assets
CN¥967.09 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2019)

This chart shows how Lifecome Biochemistry Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Lifecome Biochemistry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥45.35 Million 4.69%
Total Liquid Assets CN¥45.35 Million 4.69%

Asset Resilience Insights

  • Limited Liquidity: Lifecome Biochemistry Co Ltd maintains only 4.69% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Lifecome Biochemistry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Lifecome Biochemistry Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Lifecome Biochemistry Co Ltd (2019–2019)

The table below shows the annual Asset Resilience Ratio data for Lifecome Biochemistry Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-12-31 17.13% CN¥173.03 Million CN¥1.01 Billion --
pp = percentage points